"CFTRI has submitted analysis reports on Maggi noodles to the Supreme Court. We have been provided with a copy of the reports. We are happy that all 29 samples tested by CFTRI are clear," Nestle India said in a statement.
The reports state that lead levels for all samples are within permissible limits, it added.
"All 29 samples of Maggi Noodles,( the initial 13 and subsequent 16 samples), were collected by the relevant authorities following due process and then directly submitted to CFTRI," Nestle India said.
"Every single sample was found compliant," the company said.
More From This Section
The Supreme Court on December 16 last year, ordered testing of samples of Maggi noodles in Mysore laboratory after the National Consumer Disputes Redressal Commission (NCDRC) had directed that it be done in Chennai.
The apex court had passed the December order after noting that both the Centre and Nestle India had agreed that Mysore was well equipped with all tests and being a referral notified laboratory, and sample should be sent there.
Nestle India said CFTRI has clarified that glutamic acid can be due to presence of ingredients like tomatoes, cheese, hydrolyzed plant protein, hydrolyzed vegetable protein. It has further stated that there are no analytical methods to distinguish between naturally present glutamic acid and additive MSG.
Nestle India further said the CFTRI has clarified that the additive MSG is allowed to be added to selected food commodities (seasoning for Noodles is one of them) under Good Manufacturing Practices basis proper label declarations as per 'Food Safety and Standards Regulations, 2011'.
product was "unsafe and hazardous" for consumption after finding lead levels beyond permissible limits.
Nestle had relaunched Maggi noodles in the market on November 9, 2015 after fulfilling conditions set by Bombay High Court which lifted ban imposed by FSSAI and Maharashtra FDA, which banned the product citing excessive lead content and MSG.
With the CFTRI report in place, Nestle India said it is working diligently to re-introduce more variants very soon.